Lapatinib Intermediate

Lapatinib Intermediate  is a Kinase Inhibitor. The mechanism of action of lapatinib is as a Protein Kinase Inhibitor. Lapatinib is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib, an oral breast cancer drug, has recently been reported to be a mechanism-based inactivator of cytochrome P450 (P450) 3A4 and also an idiosyncratic hepatotoxicant. The Lapatinib Intermediate come with optimal purity averaging around 97% to 99% and have distinct melting points.